- Impact of diabetes duration and hyperglycemia on the progres... 2025-04-25
- Therapeutic potential of integrins in diabetic retinopathy 2025-04-25
- Immunosuppressive agents in diabetes treatment: Hope or desp... 2025-04-25
- Intelligent hydrogel-based dressings for the treatment of ch... 2025-04-25
- Targeting gut microbiota and its associated metabolites as a... 2025-04-25
World Journal of Diabetes (WJD, World J Diabetes) is a high-quality, open-access academic journal that employs a single-blind peer-review process. The journal focuses on publishing innovative, novel, and practical clinical, basic, and translational research achievements in the fields of diabetes. The types of articles published in WJD include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. All submissions must comply with academic norms and ethical requirements. The journal is edited and published by the Baishideng Publishing Group. Submit here >>
- Lu Cai, MD, PhD, Professor, (E-mail: l0cai001@louisville.edu) Pediatric Research Institute, University of Louisville, Louisville, KY 40202, United States
- Michael Horowitz, PhD, MD, Professor, (E-mail: michael.horowitz@adelaide.edu.au) Department of Medicine, Royal Adelaide Hospital, Adelaide 5005, Australia
- Md. Shahidul Islam, PhD, Professor, (E-mail: islamd@ukzn.ac.za) Department of Biochemistry, University of KwaZulu-Natal, Durban 4000, South Africa
The 2024 edition of Journal Citation Reports® cites the 2023 journal impact factor (JIF) for WJD as 4.2; JIF without journal self cites: 4.1; 5-year JIF: 4.2; JIF Rank: 40/186 in endocrinology and metabolism; JIF Quartile: Q1; and 5-year JIF Quartile: Q2.























